Trial Profile
Insulin glargine 300 U/ml versus insulin degludec 100 U/ml in type 2 diabetic patients treated with basal-bolus insulin therapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Feb 2017 Status changed from recruiting to discontinued.
- 11 Dec 2015 New trial record